FDA Inspection 925969 — Fresenius Kabi AB
The FDA completed an inspection of Fresenius Kabi AB on March 20, 2015 in Uppsala. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Devices.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- March 20, 2015
- Fiscal Year
- 2015
- Product Type
- Devices
- Project Area
- Bioresearch Monitoring
- Location
- Uppsala (Sweden)
Additional Details
Postmarket Audit Inspections